KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Invested Capital (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Return on Invested Capital for 3 consecutive years, with 0.66% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Return on Invested Capital rose 181.0% year-over-year to 0.66%, compared with a TTM value of 0.66% through Sep 2023, up 181.0%, and an annual FY2022 reading of 1.33%, up 47.0% over the prior year.
  • Return on Invested Capital was 0.66% for Q3 2023 at Ginkgo Bioworks Holdings, up from 0.82% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.66% in Q3 2023 and bottomed at 2.46% in Q3 2022.
  • Average Return on Invested Capital over 3 years is 1.25%, with a median of 1.09% recorded in 2021.
  • The sharpest move saw Return on Invested Capital decreased -23bps in 2022, then soared 181bps in 2023.
  • Year by year, Return on Invested Capital stood at 1.15% in 2021, then decreased by -20bps to 1.38% in 2022, then surged by 52bps to 0.66% in 2023.
  • Business Quant data shows Return on Invested Capital for DNA at 0.66% in Q3 2023, 0.82% in Q2 2023, and 1.04% in Q1 2023.